Literature DB >> 27697773

High incidence of activating STAT5B mutations in CD4-positive T-cell large granular lymphocyte leukemia.

Emma I Andersson1, Takahiro Tanahashi2, Nodoka Sekiguchi3,4, Vanessa Rebecca Gasparini1, Sabrina Bortoluzzi1, Toru Kawakami3, Kazuyuki Matsuda5, Takeki Mitsui6, Samuli Eldfors7, Stefania Bortoluzzi8, Alessandro Coppe8, Andrea Binatti8, Sonja Lagström7, Pekka Ellonen7, Noriyasu Fukushima9, Sayaka Nishina3, Noriko Senoo3, Hitoshi Sakai4, Hideyuki Nakazawa3, Yok-Lam Kwong10, Thomas P Loughran11, Jaroslaw P Maciejewski12, Satu Mustjoki1,13, Fumihiro Ishida2,3,14.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27697773      PMCID: PMC5114490          DOI: 10.1182/blood-2016-06-724856

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  19 in total

1.  WHO classification of tumours of haematopoietic and lymphoid tissues in 2008: an overview.

Authors:  E Sabattini; F Bacci; C Sagramoso; S A Pileri
Journal:  Pathologica       Date:  2010-06

2.  Somatic STAT3 mutations in large granular lymphocytic leukemia.

Authors:  Hanna L M Koskela; Samuli Eldfors; Pekka Ellonen; Arjan J van Adrichem; Heikki Kuusanmäki; Emma I Andersson; Sonja Lagström; Michael J Clemente; Thomas Olson; Sari E Jalkanen; Muntasir Mamun Majumder; Henrikki Almusa; Henrik Edgren; Maija Lepistö; Pirkko Mattila; Kathryn Guinta; Pirjo Koistinen; Taru Kuittinen; Kati Penttinen; Alun Parsons; Jonathan Knowles; Janna Saarela; Krister Wennerberg; Olli Kallioniemi; Kimmo Porkka; Thomas P Loughran; Caroline A Heckman; Jaroslaw P Maciejewski; Satu Mustjoki
Journal:  N Engl J Med       Date:  2012-05-17       Impact factor: 91.245

3.  Laboratory findings in CD4(+) large granular lymphocytoses.

Authors:  H Olteanu; N J Karandikar; C Eshoa; S H Kroft
Journal:  Int J Lab Hematol       Date:  2008-10-08       Impact factor: 2.877

4.  Novel activating STAT5B mutations as putative drivers of T-cell acute lymphoblastic leukemia.

Authors:  M Kontro; H Kuusanmäki; S Eldfors; T Burmeister; E I Andersson; O Bruserud; T H Brümmendorf; H Edgren; B T Gjertsen; M Itälä-Remes; S Lagström; O Lohi; T Lundán; J M L Martí; M M Majumder; A Parsons; T Pemovska; H Rajala; K Vettenranta; O Kallioniemi; S Mustjoki; K Porkka; C A Heckman
Journal:  Leukemia       Date:  2014-02-27       Impact factor: 11.528

5.  The analysis of clonal diversity and therapy responses using STAT3 mutations as a molecular marker in large granular lymphocytic leukemia.

Authors:  Hanna L M Rajala; Thomas Olson; Michael J Clemente; Sonja Lagström; Pekka Ellonen; Tuija Lundan; David E Hamm; Syed Arshi Uz Zaman; Jesus M Lopez Marti; Emma I Andersson; Andres Jerez; Kimmo Porkka; Jaroslaw P Maciejewski; Thomas P Loughran; Satu Mustjoki
Journal:  Haematologica       Date:  2014-10-03       Impact factor: 9.941

6.  Activating mutations of STAT5B and STAT3 in lymphomas derived from γδ-T or NK cells.

Authors:  Can Küçük; Bei Jiang; Xiaozhou Hu; Wenyan Zhang; John K C Chan; Wenming Xiao; Nathan Lack; Can Alkan; John C Williams; Kendra N Avery; Pınar Kavak; Anna Scuto; Emel Sen; Philippe Gaulard; Lou Staudt; Javeed Iqbal; Weiwei Zhang; Adam Cornish; Qiang Gong; Qunpei Yang; Hong Sun; Francesco d'Amore; Sirpa Leppä; Weiping Liu; Kai Fu; Laurence de Leval; Timothy McKeithan; Wing C Chan
Journal:  Nat Commun       Date:  2015-01-14       Impact factor: 14.919

7.  Monoclonal TCR-Vbeta13.1+/CD4+/NKa+/CD8-/+dim T-LGL lymphocytosis: evidence for an antigen-driven chronic T-cell stimulation origin.

Authors:  Pilar Garrido; Francisco Ruiz-Cabello; Paloma Bárcena; Yorick Sandberg; Julia Cantón; Margarida Lima; Ana Balanzategui; Marcos González; Miguel Angel López-Nevot; Anton W Langerak; Andrés C García-Montero; Julia Almeida; Alberto Orfao
Journal:  Blood       Date:  2007-02-15       Impact factor: 22.113

8.  Discovery of somatic STAT5b mutations in large granular lymphocytic leukemia.

Authors:  Hanna L M Rajala; Samuli Eldfors; Heikki Kuusanmäki; Arjan J van Adrichem; Thomas Olson; Sonja Lagström; Emma I Andersson; Andres Jerez; Michael J Clemente; Yiyi Yan; Dan Zhang; Andy Awwad; Pekka Ellonen; Olli Kallioniemi; Krister Wennerberg; Kimmo Porkka; Jaroslaw P Maciejewski; Thomas P Loughran; Caroline Heckman; Satu Mustjoki
Journal:  Blood       Date:  2013-04-17       Impact factor: 22.113

9.  TCRalphabeta+/CD4+ large granular lymphocytosis: a new clonal T-cell lymphoproliferative disorder.

Authors:  Margarida Lima; Julia Almeida; Maria Dos Anjos Teixeira; Maria del Carmen Alguero Md; Ana Helena Santos; Ana Balanzategui; Maria Luís Queirós; Paloma Bárcena; Antonio Izarra; Sónia Fonseca; Clara Bueno; Benvindo Justiça; Marcos Gonzalez; Jesús F San Miguel; Alberto Orfao
Journal:  Am J Pathol       Date:  2003-08       Impact factor: 4.307

10.  JAK-STAT and G-protein-coupled receptor signaling pathways are frequently altered in epitheliotropic intestinal T-cell lymphoma.

Authors:  M-L Nairismägi; J Tan; J Q Lim; S Nagarajan; C C Y Ng; V Rajasegaran; D Huang; W K Lim; Y Laurensia; G C Wijaya; Z M Li; I Cutcutache; W L Pang; S Thangaraju; J Ha; L P Khoo; S T Chin; S Dey; G Poore; L H C Tan; H K M Koh; K Sabai; H-L Rao; K L Chuah; Y-H Ho; S-B Ng; S-S Chuang; F Zhang; Y-H Liu; T Pongpruttipan; Y H Ko; P-L Cheah; N Karim; W-J Chng; T Tang; M Tao; K Tay; M Farid; R Quek; S G Rozen; P Tan; B T Teh; S T Lim; S-Y Tan; C K Ong
Journal:  Leukemia       Date:  2016-02-08       Impact factor: 11.528

View more
  29 in total

Review 1.  Chronic neutropenia in LGL leukemia and rheumatoid arthritis.

Authors:  Tal Gazitt; Thomas P Loughran
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

2.  Systematic STAT3 sequencing in patients with unexplained cytopenias identifies unsuspected large granular lymphocytic leukemia.

Authors:  Elizabeth A Morgan; Mark N Lee; Daniel J DeAngelo; David P Steensma; Richard M Stone; Frank C Kuo; Jon C Aster; Christopher J Gibson; R Coleman Lindsley
Journal:  Blood Adv       Date:  2017-09-13

3.  Oral cyclophosphamide was effective for Coombs-negative autoimmune hemolytic anemia in CD16+CD56- chronic lymphoproliferative disorder of NK-cells.

Authors:  Nodoka Sekiguchi; Sayaka Nishina; Toru Kawakami; Hitoshi Sakai; Noriko Senoo; Yasushi Senoo; Toshiro Ito; Hiroshi Saito; Hideyuki Nakazawa; Tomonobu Koizumi; Fumihiro Ishida
Journal:  Int J Hematol       Date:  2016-12-27       Impact factor: 2.490

Review 4.  All that glitters is not LGL Leukemia.

Authors:  Gianpietro Semenzato; Antonella Teramo; Giulia Calabretto; Vanessa Rebecca Gasparini; Renato Zambello
Journal:  Leukemia       Date:  2022-09-15       Impact factor: 12.883

5.  Defining TCRγδ lymphoproliferative disorders by combined immunophenotypic and molecular evaluation.

Authors:  Antonella Teramo; Andrea Binatti; Elena Ciabatti; Gianluca Schiavoni; Giulia Tarrini; Gregorio Barilà; Giulia Calabretto; Cristina Vicenzetto; Vanessa Rebecca Gasparini; Monica Facco; Iacopo Petrini; Roberto Grossi; Nadia Pisanti; Stefania Bortoluzzi; Brunangelo Falini; Enrico Tiacci; Sara Galimberti; Gianpietro Semenzato; Renato Zambello
Journal:  Nat Commun       Date:  2022-06-08       Impact factor: 17.694

Review 6.  Genomics of LGL leukemia and select other rare leukemia/lymphomas.

Authors:  Katharine B Moosic; Umadevi Paila; Kristine C Olson; Karolina Dziewulska; T Tiffany Wang; Jeffrey C Xing; Aakrosh Ratan; David J Feith; Thomas P Loughran; Thomas L Olson
Journal:  Best Pract Res Clin Haematol       Date:  2019-06-06       Impact factor: 3.020

7.  Somatic mutations in lymphocytes in patients with immune-mediated aplastic anemia.

Authors:  Sofie Lundgren; Mikko A I Keränen; Jaroslaw P Maciejewski; Eva Hellström-Lindberg; Matti Kankainen; Jani Huuhtanen; Gunilla Walldin; Cassandra M Kerr; Michael Clemente; Freja Ebeling; Hanna Rajala; Oscar Brück; Harri Lähdesmäki; Sari Hannula; Tiina Hannunen; Pekka Ellonen; Neal S Young; Seishi Ogawa; Satu Mustjoki
Journal:  Leukemia       Date:  2021-03-30       Impact factor: 11.528

8.  STAT3 and STAT5B mutations have unique distribution in T-cell large granular lymphocyte proliferations and advanced myeloid neoplasms.

Authors:  Shiqiang Qu; Yujiao Jia; Huijun Wang; Xiaofei Ai; Zefeng Xu; Tiejun Qin; Lijuan Pan; Bing Li; Gang Huang; Robert Peter Gale; Zhijian Xiao
Journal:  Leuk Lymphoma       Date:  2021-01-07

Review 9.  Untwining Anti-Tumor and Immunosuppressive Effects of JAK Inhibitors-A Strategy for Hematological Malignancies?

Authors:  Klara Klein; Dagmar Stoiber; Veronika Sexl; Agnieszka Witalisz-Siepracka
Journal:  Cancers (Basel)       Date:  2021-05-26       Impact factor: 6.639

Review 10.  IL-2 Signaling Axis Defects: How Many Faces?

Authors:  Filippo Consonni; Claudio Favre; Eleonora Gambineri
Journal:  Front Pediatr       Date:  2021-07-02       Impact factor: 3.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.